Filing Details

Accession Number:
0001104659-19-046144
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-15 16:06:42
Reporting Period:
2019-08-13
Accepted Time:
2019-08-15 16:06:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1047579 K Richard Prins C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-13 10,000 $15.11 49,309 No 4 M Direct
Common Stock Disposition 2019-08-13 10,000 $20.78 39,309 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2019-08-13 10,000 $0.00 10,000 $15.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,782 2020-05-27 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.62 to $20.865, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. Shares subject to the option are fully vested and immediately exercisable.